Study Results Could Help Improve Treatment for Alcohol-Related Problems
By Brandon Levy
Tuesday, April 16, 2019
Your brain is always busy, even when you’re not thinking about anything. Scientists believe the way brain cells communicate with one another when the brain is in that ‘resting state’ might differ in individuals with certain diseases. In a recent study of this idea, IRP researchers found that resting state brain activity could effectively predict the severity of alcohol-related problems.
Computational Biology Research Conducted at NIH Garners $25,000 Prize
By Brandon Levy
Monday, April 8, 2019
The IRP is home to some of today’s and tomorrow’s greatest scientific minds. Hundreds of budding biomedical pioneers begin honing their scientific skills here in high school, but very few win distinction as quickly as seventeen-year-old Daniel Schäffer, whose IRP research earned him inclusion among this year’s 40 finalists in the prestigious Regeneron Science Talent Search.
New System Could Boost Treatment Effectiveness and Curb Side Effects
By Brandon Levy
Tuesday, April 2, 2019
Cancer kills more than half a million men, women, and children each year in the U.S, and chemotherapy is only slightly more discriminating than the disease it treats. As a result, many cancer treatments kill cells throughout the body and cause severe side effects. New IRP research could solve this problem by creating a way to release those toxic compounds only when and where doctors desire.
By Michele Lyons
Tuesday, March 26, 2019
As Women's History month draws to a close, we’d like to introduce you to some of the IRP researchers who have received the honor of delivering the Anita B. Roberts Lecture. The Anita B. Roberts Lecture Series is organized by the NIH Women Scientist Advisors Committee to highlight outstanding research achievements by female scientists at NIH. The series is supported by the Office of Research on Women’s Health.
Discovery Could Lead to New Approaches for Boosting Blood Cell Counts
By Brandon Levy
Tuesday, March 19, 2019
Much of human biology is a black box — scientists know the key players and the end results, but not how those outcomes come about. Consequently, it remains a mystery why some medications help patients. A new IRP study has cracked open the black box to reveal how high levels of an inflammatory molecule inhibit blood cell production in some individuals and why a particular medicine helps reverse this life-threatening condition.
By Michele Lyons
Thursday, March 14, 2019
Surrounded as we are with incredible technologies like supercomputers, MRI scanners, and smartphones, it's easy to forget that technologies viewed as antiquated today were once considered cutting-edge. Perhaps learning about some of the gadgets and technological concerns from NIH's past will help spark a greater appreciation for the wonderful gizmos that are spurring new scientific discoveries (and adorable cat memes) today.
Alternative to CRISPR/Cas9 May Cause Fewer Undesired Changes
By Brandon Levy
Tuesday, March 5, 2019
IRP researchers have always worked on the cutting edge of biomedical science, from testing the first successful treatment for childhood schizophrenia to pioneering the first screening technique for HIV. In a new study, an IRP team recently achieved yet another first: simultaneously editing two genetic sites in mice using a brand-new approach called base editing that may prove to be more precise – and therefore safer – than other gene editing methods.
By Brandon Levy
Thursday, February 28, 2019
The NIH’s main campus in Bethesda, Maryland, may have the look and feel of a university campus, but the world-renowned research institution does not grant credentials like an M.D. or Ph.D. Instead, the Graduate Partnerships Program offers graduate students from schools around the world the opportunity to complete research for their Ph.D. dissertations in IRP labs while pursuing advanced degrees from their ‘host’ institutions.
By Lindsey Jay
Tuesday, February 26, 2019
What does a postbac actually do in the NIH IRP? Maybe you have an image of someone mixing colorful chemicals together like a mad scientist (which sometimes isn’t too far from the truth).
Although I am not creating any diabolical concoctions, I am kept quite busy running tests to examine whether our treatments reverse the effects of lung fibrosis, a thickening and scarring of lung tissue. Here’s what a typical week looks like for me.
Delivery Method Could Eventually Help Correct Mutations That Cause Hearing Loss
By Brandon Levy
Tuesday, February 19, 2019
Most people probably think of viruses as villains that bring illnesses like measles, HIV, and the flu, but some viruses are proving to be valuable allies in the fight against genetic diseases. In a new study, a team of scientists from the NIH IRP and their colleagues showed the promise of a lab-designed virus for delivering gene therapies aimed at correcting hereditary hearing loss.
